Skip to main content
  1. Home
  2. Emerging Tech
  3. News

Test your blood from the comfort of your home with Athelas

By
Athelas
Blood testing startup Theranos may be dead in the water, but that doesn’t mean that the concept behind the disgraced startup has disappeared. Really, it has just found a new champion. Meet
Recommended Videos
Athelas, heralded as an instant blood diagnostics system capable of testing for diseases such as the flu, bacterial infections, and even cancer. Best of all? You can do all your testing from the comfort of your own home.

Founded by Tanay Tandon when he was just 17, the three-year-old startup was initially intended to detect malaria via blood samples. But now, Tandon has expanded Athelas’ capabilities. The cylindrical device (which looks a bit like an Amazon Echo) allows you to insert a slide with a few drops of your blood, and then determines whether your white blood cell count is abnormal. Your results are delivered to you via a companion app, and should be viewable within 60 seconds.

Powered by computer imaging and developed in conjunction with oncologists (who are apparently already lending these devices to their patients), Athelas wants to avoid the nightmare that was the Elizabeth Holmes and Theranos debacle. Of course, it helps that the Athelas team is rife with medical expertise, and already enjoys clinical validation of its results. Moreover, Athelas is FDA-approved, and can be used for imaging diagnostics.

As it stands, the firm expects the device to be used mainly at home, but there are plans for hospitals to take advantage of the device for triage purposes. And apparently, there are partnerships with pharmaceutical companies brewing as well.

“One of our goals is to become a companion diagnostic for a lot of these interesting drugs,” Tandon told TechCrunch.

If you’re interested in trying out an Athelas for yourself, you can either talk to a doctor about potentially acquiring a rental unit, or you can buy an Athelas straight from the the company’s website. For $20 a month, you’ll be able to take 10 tests and hopefully “flag bacterial infections, monitor Neutropenia, and generate White Blood Cell markers.” The device is set to begin shipping on September 28, 2017, and the company promises not to charge customers until they receive their Athelas.

Editors' Recommendations

Topics
Lulu Chang
Lulu Chang
Former Digital Trends Contributor
Fascinated by the effects of technology on human interaction, Lulu believes that if her parents can use your new app…
Bill Gates is funding an at-home coronavirus testing program
Bill Gates

To find out how the coronavirus spreads through communities, Microsoft co-founder Bill Gates said he is funding an at-home self-swab test for those who live in Seattle. 

The Seattle Coronavirus Assessment Network (SCAN) is a "disease surveillance program" whose goal is to provide a clearer picture of how the coronavirus spreads through a community by testing healthy people as well as those who are sick, Gates announced in a blog post on Tuesday, May 12.

Read more
FDA authorizes at-home coronavirus test that uses your spit
Rutgers Spectrum Coronavirus Saliva Test.

The Food and Drug Administration has authorized a second at-home test for the coronavirus -- one that can detect the virus using saliva samples.

The test is made by a Rutgers University laboratory, RUCDR Infinite Biologics, in partnership with Spectrum Solutions and Accurate Diagnostic Labs. The Rutgers test uses a saliva collection device and must be sent back to the lab for testing. You can only receive the test if it’s been ordered through a physician.

Read more
FDA authorizes first at-home coronavirus test
fda authorizes first at home coronavirus test pixel labcorp

In response to a mass shortage of available tests, the Food and Drug Administration (FDA) has authorized a direct-to-consumer test for the coronavirus, officially known as COVID-19. 

The test, called Pixel and created by health services giant LabCorp, will be priced at $119 and includes two-way overnight shipping and physician services from PWNHealth. 

Read more